
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Data-Driven Mathematical Model of Osteosarcoma
Trang Le, Sumeyye Su, Arkadz Kirshtein, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2367-2367
Open Access | Times Cited: 29
Trang Le, Sumeyye Su, Arkadz Kirshtein, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2367-2367
Open Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment
Hailong Tian, Jiangjun Cao, Bowen Li, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 106
Hailong Tian, Jiangjun Cao, Bowen Li, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 106
Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications
Tianyi Zhu, Jing Han, Yang Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 73
Tianyi Zhu, Jing Han, Yang Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 73
Advances on immunotherapy for osteosarcoma
Shengnan Yu, Xudong Yao
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 38
Shengnan Yu, Xudong Yao
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 38
Novel Immunotherapies for Osteosarcoma
Yubao Lu, Jiahe Zhang, Yutong Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 45
Yubao Lu, Jiahe Zhang, Yutong Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 45
A telomere-related signature for predicting prognosis and assessing immune microenvironment in osteosarcoma
Shihao Li, Lina Zhang, Haiyang Zhang
Frontiers in Pharmacology (2025) Vol. 15
Open Access | Times Cited: 1
Shihao Li, Lina Zhang, Haiyang Zhang
Frontiers in Pharmacology (2025) Vol. 15
Open Access | Times Cited: 1
Digging Through the Complexities of Immunological Approaches in Emerging Osteosarcoma Therapeutics: A Comprehensive Narrative Review with Updated Clinical Trials
Consolato Sergi, Mervin Burnett, Eugeniu Jantuan, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 664-664
Open Access | Times Cited: 1
Consolato Sergi, Mervin Burnett, Eugeniu Jantuan, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 664-664
Open Access | Times Cited: 1
Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies
Hang Liang, Min Cui, Jingyao Tu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 6
Hang Liang, Min Cui, Jingyao Tu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 6
Decoding the Impact of Tumor Microenvironment in Osteosarcoma Progression and Metastasis
Bikesh K. Nirala, Taku Yamamichi, D. Isabel Petrescu, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5108-5108
Open Access | Times Cited: 16
Bikesh K. Nirala, Taku Yamamichi, D. Isabel Petrescu, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5108-5108
Open Access | Times Cited: 16
Integral invariant manifold method applied to a mathematical model of osteosarcoma
Ophir Nave
Results in Control and Optimization (2025), pp. 100529-100529
Open Access
Ophir Nave
Results in Control and Optimization (2025), pp. 100529-100529
Open Access
Tumor Growth, Proliferation and Diffusion in Osteosarcoma
M. I. Romero Rodríguez, James C. Pino, E L Sierra-Ballén
Acta Biotheoretica (2025) Vol. 73, Iss. 1
Open Access
M. I. Romero Rodríguez, James C. Pino, E L Sierra-Ballén
Acta Biotheoretica (2025) Vol. 73, Iss. 1
Open Access
A Mathematical Model of Breast Tumor Progression Based on Immune Infiltration
Navid Mohammad Mirzaei, Sumeyye Su, Dilruba Sofia, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 10, pp. 1031-1031
Open Access | Times Cited: 25
Navid Mohammad Mirzaei, Sumeyye Su, Dilruba Sofia, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 10, pp. 1031-1031
Open Access | Times Cited: 25
Construction of Osteosarcoma Diagnosis Model by Random Forest and Artificial Neural Network
Sheng Li, Yukang Que, Rui Yang, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 3, pp. 447-447
Open Access | Times Cited: 9
Sheng Li, Yukang Que, Rui Yang, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 3, pp. 447-447
Open Access | Times Cited: 9
Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma
Claudia Maria Hattinger, Iris C. Salaroglio, Leonardo Fantoni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 799-799
Open Access | Times Cited: 8
Claudia Maria Hattinger, Iris C. Salaroglio, Leonardo Fantoni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 799-799
Open Access | Times Cited: 8
A PDE Model of Breast Tumor Progression in MMTV-PyMT Mice
Navid Mohammad Mirzaei, Zuzana Tatárová, Wenrui Hao, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 5, pp. 807-807
Open Access | Times Cited: 12
Navid Mohammad Mirzaei, Zuzana Tatárová, Wenrui Hao, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 5, pp. 807-807
Open Access | Times Cited: 12
Investigating Optimal Chemotherapy Options for Osteosarcoma Patients through a Mathematical Model
Trang Le, Sumeyye Su, Leili Shahriyari
Cells (2021) Vol. 10, Iss. 8, pp. 2009-2009
Open Access | Times Cited: 15
Trang Le, Sumeyye Su, Leili Shahriyari
Cells (2021) Vol. 10, Iss. 8, pp. 2009-2009
Open Access | Times Cited: 15
Investigating key cell types and molecules dynamics in PyMT mice model of breast cancer through a mathematical model
Navid Mohammad Mirzaei, Navid Changizi, Alireza Asadpoure, et al.
PLoS Computational Biology (2022) Vol. 18, Iss. 3, pp. e1009953-e1009953
Open Access | Times Cited: 8
Navid Mohammad Mirzaei, Navid Changizi, Alireza Asadpoure, et al.
PLoS Computational Biology (2022) Vol. 18, Iss. 3, pp. e1009953-e1009953
Open Access | Times Cited: 8
Mathematical and Machine Learning Models of Renal Cell Carcinoma: A Review
Dilruba Sofia, Q. Zhou, Leili Shahriyari
Bioengineering (2023) Vol. 10, Iss. 11, pp. 1320-1320
Open Access | Times Cited: 4
Dilruba Sofia, Q. Zhou, Leili Shahriyari
Bioengineering (2023) Vol. 10, Iss. 11, pp. 1320-1320
Open Access | Times Cited: 4
Modeling cancer progression: an integrated workflow extending data-driven kinetic models to bio-mechanical PDE models
Navid Mohammad Mirzaei, Leili Shahriyari
Physical Biology (2024) Vol. 21, Iss. 2, pp. 022001-022001
Open Access | Times Cited: 1
Navid Mohammad Mirzaei, Leili Shahriyari
Physical Biology (2024) Vol. 21, Iss. 2, pp. 022001-022001
Open Access | Times Cited: 1
Exploration of metastasis-related signatures in osteosarcoma based on tumor microenvironment by integrated bioinformatic analysis
Shiyao Liao, Xing Gao, Kai Zhou, et al.
Heliyon (2024) Vol. 11, Iss. 1, pp. e41358-e41358
Open Access | Times Cited: 1
Shiyao Liao, Xing Gao, Kai Zhou, et al.
Heliyon (2024) Vol. 11, Iss. 1, pp. e41358-e41358
Open Access | Times Cited: 1
Characteristics and significance of T lymphocyte subsets in peripheral blood of osteosarcoma mice
Qi Liu, Rui Xu, Xuan Xu, et al.
Translational Cancer Research (2022) Vol. 11, Iss. 6, pp. 1503-1509
Open Access | Times Cited: 7
Qi Liu, Rui Xu, Xuan Xu, et al.
Translational Cancer Research (2022) Vol. 11, Iss. 6, pp. 1503-1509
Open Access | Times Cited: 7
Heparin and Heparin-Based Drug Delivery Systems: Pleiotropic Molecular Effects at Multiple Drug Resistance of Osteosarcoma and Immune Cells
Н. М. Тодосенко, K. А. Yurova, О. Г. Хазиахматова, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2181-2181
Open Access | Times Cited: 6
Н. М. Тодосенко, K. А. Yurova, О. Г. Хазиахматова, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2181-2181
Open Access | Times Cited: 6
Investigating the spatial interaction of immune cells in colon cancer
Navid Mohammad Mirzaei, Wenrui Hao, Leili Shahriyari
iScience (2023) Vol. 26, Iss. 5, pp. 106596-106596
Open Access | Times Cited: 3
Navid Mohammad Mirzaei, Wenrui Hao, Leili Shahriyari
iScience (2023) Vol. 26, Iss. 5, pp. 106596-106596
Open Access | Times Cited: 3
Bio-Mechanical Model of Osteosarcoma Tumor Microenvironment: A Porous Media Approach
Yu Hu, Navid Mohammad Mirzaei, Leili Shahriyari
Cancers (2022) Vol. 14, Iss. 24, pp. 6143-6143
Open Access | Times Cited: 5
Yu Hu, Navid Mohammad Mirzaei, Leili Shahriyari
Cancers (2022) Vol. 14, Iss. 24, pp. 6143-6143
Open Access | Times Cited: 5
Necroptosis in the sarcoma immune microenvironment: From biology to therapy
Huali Ye, Minxun Lu, Chongqi Tu, et al.
International Immunopharmacology (2023) Vol. 122, pp. 110603-110603
Closed Access | Times Cited: 2
Huali Ye, Minxun Lu, Chongqi Tu, et al.
International Immunopharmacology (2023) Vol. 122, pp. 110603-110603
Closed Access | Times Cited: 2
Ferroptosis-related lncRNAs guiding osteosarcoma prognosis and immune microenvironment
Mingyi Yang, Yani Su, Ke Xu, et al.
Journal of Orthopaedic Surgery and Research (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Mingyi Yang, Yani Su, Ke Xu, et al.
Journal of Orthopaedic Surgery and Research (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 2